+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Age-related Macular Degeneration Market 2021-2025- Product Image
Global Age-related Macular Degeneration Market 2021-2025- Product Image

Global Age-related Macular Degeneration Market 2021-2025

  • ID: 5362671
  • Report
  • June 2021
  • Region: Global
  • 120 pages
  • TechNavio

FEATURED COMPANIES

  • AbbVie Inc.
  • Amgen Inc.
  • Bayer AG
  • F. Hoffmann-La Roche Ltd.
  • Lupin Ltd.
  • Novartis AG
  • MORE
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher has been monitoring the age-related macular degeneration market and it is poised to grow by $ 4.00 billion during 2021-2025, progressing at a CAGR of almost 6% during the forecast period. The report on the age-related macular degeneration market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the high prevalence of AMD and the rising geriatric population.

The age-related macular degeneration market analysis includes the type segment and geographic landscape.

The age-related macular degeneration market is segmented as below:

By Type
  • Wet AMD
  • Dry AMD
By Geographical Landscape
  • North America
  • Europe
  • Asia
  • ROW
This study identifies the strong pipeline and expected approvals as one of the prime reasons driving the age-related macular degeneration market growth during the next few years.

The report on age-related macular degeneration market covers the following areas:
  • Age-related macular degeneration market sizing
  • Age-related macular degeneration market forecast
  • Age-related macular degeneration market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading age-related macular degeneration market vendors that include AbbVie Inc., Alkeus Pharmaceuticals Inc., Amgen Inc., Bausch Health Companies Inc., Bayer AG, F. Hoffmann-La Roche Ltd., Lupin Ltd., Novartis AG, Pfizer Inc., and Regeneron Pharmaceuticals Inc. Also, the age-related macular degeneration market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AbbVie Inc.
  • Amgen Inc.
  • Bayer AG
  • F. Hoffmann-La Roche Ltd.
  • Lupin Ltd.
  • Novartis AG
  • MORE
Executive Summary
  • Market overview
Market Landscape
  • Market ecosystem
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025
Five Forces Analysis
  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Market Segmentation by Type
  • Market segments
  • Comparison by Type
  • Wet AMD - Market size and forecast 2020-2025
  • Dry AMD - Market size and forecast 2020-2025
  • Market opportunity by Type
Customer landscape
  • Overview
Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity By Geographical Landscape
  • Market drivers
  • Market challenges
  • Market trends
Vendor Landscape
  • Overview
  • Landscape disruption
Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • AbbVie Inc.
  • Alkeus Pharmaceuticals Inc.
  • Amgen Inc.
  • Bausch Health Companies Inc.
  • Bayer AG
  • F. Hoffmann-La Roche Ltd.
  • Lupin Ltd.
  • Novartis AG
  • Pfizer Inc.
  • Regeneron Pharmaceuticals Inc.
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations
List of Exhibits
  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2020 - 2025 ($ million)
  • Global market: Year-over-year growth 2020 - 2025 (%)
  • Five forces analysis 2020 & 2025
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2020
  • Type - Market share 2020-2025 (%)
  • Comparison by Type
  • Wet AMD - Market size and forecast 2020-2025 ($ million)
  • Wet AMD - Year-over-year growth 2020-2025 (%)
  • Dry AMD - Market size and forecast 2020-2025 ($ million)
  • Dry AMD - Year-over-year growth 2020-2025 (%)
  • Market opportunity by Type
  • Customer landscape
  • Market share By Geographical Landscape 2020-2025 (%)
  • Geographic comparison
  • North America - Market size and forecast 2020-2025 ($ million)
  • North America - Year-over-year growth 2020-2025 (%)
  • Europe - Market size and forecast 2020-2025 ($ million)
  • Europe - Year-over-year growth 2020-2025 (%)
  • Asia - Market size and forecast 2020-2025 ($ million)
  • Asia - Year-over-year growth 2020-2025 (%)
  • ROW - Market size and forecast 2020-2025 ($ million)
  • ROW - Year-over-year growth 2020-2025 (%)
  • Key leading countries
  • Market opportunity By Geographical Landscape ($ million)
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • AbbVie Inc. - Overview
  • AbbVie Inc. - Product and service
  • AbbVie Inc. - Key offerings
  • AbbVie Inc. - Key customers
  • AbbVie Inc. - Segment focus
  • Alkeus Pharmaceuticals Inc. - Overview
  • Alkeus Pharmaceuticals Inc. - Product and service
  • Alkeus Pharmaceuticals Inc. - Key offerings
  • Alkeus Pharmaceuticals Inc. - Key customers
  • Alkeus Pharmaceuticals Inc. - Segment focus
  • Amgen Inc. - Overview
  • Amgen Inc. - Business segments
  • Amgen Inc. - Key offerings
  • Amgen Inc. - Key customers
  • Amgen Inc. - Segment focus
  • Bausch Health Companies Inc. - Overview
  • Bausch Health Companies Inc. - Business segments
  • Bausch Health Companies Inc. - Key offerings
  • Bausch Health Companies Inc. - Key customers
  • Bausch Health Companies Inc. - Segment focus
  • Bayer AG - Overview
  • Bayer AG - Business segments
  • Bayer AG - Key offerings
  • Bayer AG - Key customers
  • Bayer AG - Segment focus
  • F. Hoffmann-La Roche Ltd. - Overview
  • F. Hoffmann-La Roche Ltd. - Business segments
  • F. Hoffmann-La Roche Ltd. - Key offerings
  • F. Hoffmann-La Roche Ltd. - Key customers
  • F. Hoffmann-La Roche Ltd. - Segment focus
  • Lupin Ltd. - Overview
  • Lupin Ltd. - Product and service
  • Lupin Ltd. - Key offerings
  • Lupin Ltd. - Key customers
  • Lupin Ltd. - Segment focus
  • Novartis AG - Overview
  • Novartis AG - Business segments
  • Novartis AG - Key offerings
  • Novartis AG - Key customers
  • Novartis AG - Segment focus
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Business segments
  • Pfizer Inc. - Key offerings
  • Pfizer Inc. - Key customers
  • Pfizer Inc. - Segment focus
  • Regeneron Pharmaceuticals Inc. - Overview
  • Regeneron Pharmaceuticals Inc. - Product and service
  • Regeneron Pharmaceuticals Inc. - Key offerings
  • Regeneron Pharmaceuticals Inc. - Key customers
  • Regeneron Pharmaceuticals Inc. - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AbbVie Inc.
  • Amgen Inc.
  • Bayer AG
  • F. Hoffmann-La Roche Ltd.
  • Lupin Ltd.
  • Novartis AG
  • MORE
The publisher recognizes the following companies as the key players in the global age-related macular degeneration market: AbbVie Inc., Alkeus Pharmaceuticals Inc., Amgen Inc., Bausch Health Companies Inc., Bayer AG, F. Hoffmann-La Roche Ltd., Lupin Ltd., Novartis AG, Pfizer Inc., and Regeneron Pharmaceuticals Inc.

Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is the strong pipeline and expected approvals.`

According to the report, one of the major drivers for this market is the high prevalence of AMD.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
  • AbbVie Inc.
  • Alkeus Pharmaceuticals Inc.
  • Amgen Inc.
  • Bausch Health Companies Inc.
  • Bayer AG
  • F. Hoffmann-La Roche Ltd.
  • Lupin Ltd.
  • Novartis AG
  • Pfizer Inc.
  • Regeneron Pharmaceuticals Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll